rdf:type |
|
lifeskim:mentions |
|
pubmed:dateCreated |
2003-10-29
|
pubmed:abstractText |
Serious skin disorders have been associated with the use of oral antifungals in a number of case reports and series of cases. However the incidence of these disorders remains unknown.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1471-5945
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
28
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
14
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:12456265-Administration, Oral,
pubmed-meshheading:12456265-Adult,
pubmed-meshheading:12456265-Aged,
pubmed-meshheading:12456265-Antifungal Agents,
pubmed-meshheading:12456265-Cohort Studies,
pubmed-meshheading:12456265-Female,
pubmed-meshheading:12456265-Great Britain,
pubmed-meshheading:12456265-Humans,
pubmed-meshheading:12456265-Incidence,
pubmed-meshheading:12456265-Male,
pubmed-meshheading:12456265-Middle Aged,
pubmed-meshheading:12456265-Risk Factors,
pubmed-meshheading:12456265-Skin Diseases
|
pubmed:year |
2002
|
pubmed:articleTitle |
Risk of serious skin disorders among users of oral antifungals: a population-based study.
|
pubmed:affiliation |
Novartis Global Epidemiology, Barcelona, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|